What's in Abeona Therapeutics, Inc's pipeline?

Abeona Therapeutics, Inc has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Abeona Therapeutics, Inc's portfolio?

Top competitors by shared drug class: AskBio Inc, BioLab 612 LLC, Brain Neurotherapy Bio, Inc., Dipexium Pharmaceuticals, Inc., Emily de los Reyes.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abeona-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Abeona Therapeutics, Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Abeona Therapeutics, Inc pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MSI-78	MSI-78	phase 3	Antimicrobial peptide	Bacterial cell membrane	Infectious Disease
EB-101	EB-101	phase 3	Gene therapy	ABCD1 gene	Neurology

Therapeutic area mix

Hematology/Oncology · 1
Infectious Disease · 1
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AskBio Inc · 1 shared drug class
BioLab 612 LLC · 1 shared drug class
Brain Neurotherapy Bio, Inc. · 1 shared drug class
Dipexium Pharmaceuticals, Inc. · 1 shared drug class
Emily de los Reyes · 1 shared drug class
Eva Morava-Kozicz · 1 shared drug class
Guangzhou Yipinhong Pharmaceutical CO.,LTD · 1 shared drug class
4D Molecular Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Abeona Therapeutics, Inc:

Cite this brief

Drug Landscape (2026). Abeona Therapeutics, Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abeona-therapeutics-inc. Accessed 2026-05-17.